TickerFactsScreenerDevelopers

SANGAMO THERAPEUTICS, INC (SGMO) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $272.0K2010: $695.0K2011: $576.0K2012: $723.0K2013: $432.0K2014: $621.0K2015: $2.41M2016: $732.0K2017: $3.75M2018: $43.06M2019: $20.68M2020: $14.71M2021: $23.28M2022: $20.17M2023: $21.16M2024: $267.0K2025: $102.0K$102.0K
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$102.0K-61.8%
2024$267.0K-98.7%
2023$21.16M+4.9%
2022$20.17M-13.3%
2021$23.28M+58.2%
2020$14.71M-28.8%
2019$20.68M-52.0%
2018$43.06M+1048.1%
2017$3.75M+412.4%
2016$732.0K-69.6%
2015$2.41M+288.2%
2014$621.0K+43.8%
2013$432.0K-40.2%
2012$723.0K+25.5%
2011$576.0K-17.1%
2010$695.0K+155.5%
2009$272.0K—